Heroin-Induced Leukoencephalopathy.
| Autor: | Alshamam MS; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Sumbly V; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Nso N; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Saliaj M; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA., Gurung DO; Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2021 Feb 03; Vol. 13 (2), pp. e13093. Date of Electronic Publication: 2021 Feb 03. |
| DOI: | 10.7759/cureus.13093 |
| Abstrakt: | Heroin-induced leukoencephalopathy (HLE) is a rare but potentially debilitating and sometimes fatal neurological disorder. Despite the widely practiced heroin use via different routes and modalities, the syndrome is said to be rare and mostly associated with inhaling rather than injecting or snorting practices. We reviewed the literature to address the latest diagnostic, therapeutic, and prognostic measures related to the condition. Here, we present a case of a 35-year-old male who admitted to inhaling heroin 18 days ago and has been experiencing ongoing neurological symptoms for the past 17 days. Imaging was consistent with extensive white matter disease at multiple levels and different anatomical regions. Although there is no known cure for HLE, the patient benefited, somewhat, from antioxidants and physical rehabilitation. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Alshamam et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|